Search results :


More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: C01EB21

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Dyspnoea postmarketing — 10.7% - 29% 1.1% - 2.6% x x x
Headache very common, 17% - 27% x x x
Flushing very common, 16% - 25% x x x
Chest discomfort 13% - 18% x x
Electrocardiogram ST segment very common x
Gastrointestinal discomfort very common, 15% x
Electrocardiogram ST segment depression 12% - 18% x x
Angina pectoris common, 12% - 18% x x x
Chest pain very common, 7% - 19% x x x
Dizziness very common, 7% - 11% x x x
Feeling hot 5% - 8% x x
Nausea postmarketing — 6% x x x
Asthenia common x
Atrioventricular block common x x x
Cough common x
Dysgeusia common, 5% - 7% x x x
Hyperhidrosis common x
Hypoaesthesia common x
Pain in extremity common x
Palpitations common x
Paraesthesia common x
Tachycardia common x
Malaise common x
Pain in jaw common x
Oral discomfort common x
Throat irritation common x
Musculoskeletal discomfort common x
Abdominal discomfort 2% - 5% x x
Hypotension postmarketing, common x x
Vomiting postmarketing, common x x
Throat tightness postmarketing, common x x
Electrocardiogram QT corrected interval prolonged postmarketing, common x x
Wheezing postmarketing, 0.9% - 3.1% 0.7% - 1.1% x
Abdominal distension uncommon x
Anxiety uncommon x
Arthralgia uncommon x
Cardiac flutter uncommon x x
Pallor uncommon x
Tinnitus uncommon x
Erythema uncommon x
Atrioventricular block complete uncommon x
Eye pain uncommon x
Injection site pain uncommon x
Tachypnoea uncommon x
Peripheral coldness uncommon x
Generalized aching uncommon x
Vision blurred uncommon x
Bradycardia uncommon x
Depressed level of consciousness uncommon x
Insomnia uncommon x
Somnolence uncommon x
Atrial fibrillation postmarketing, uncommon x x x
Diarrhoea postmarketing, uncommon x x
Faecal incontinence postmarketing, uncommon x x
Cardiac arrest postmarketing, uncommon x x
Hypertension postmarketing, uncommon x x
Myocardial infarction postmarketing, uncommon x x
Syncope postmarketing, uncommon x x
Tremor postmarketing, uncommon x x
Abdominal pain postmarketing x
Anaphylactic shock postmarketing x x
Angioedema postmarketing x x
Atrial flutter postmarketing x
Transient ischaemic attack postmarketing, uncommon x x
Rash postmarketing x x
Block heart postmarketing x
Hypersensitivity postmarketing x x
Musculoskeletal pain postmarketing x
Pain postmarketing x
Convulsion postmarketing, uncommon x x
Cerebrovascular accident postmarketing x
Urticaria postmarketing x x
Ventricular arrhythmia postmarketing x x x
Haemorrhage intracranial postmarketing x
Respiratory arrest postmarketing x
Myalgia postmarketing x
Respiratory distress postmarketing x
Oxygen saturation decreased postmarketing x
Hypotension symptomatic postmarketing x
Supraventricular tachyarrhythmia postmarketing x
Asthma x
Mental disorder x
Connective tissue disorder x
Eye disorder x
Gastrointestinal disorder x
Cardiac disorder x
Immune system disorder x
Ischaemia x
Chronic obstructive pulmonary disease x
Mediastinal disorder x
Nervous system disorder x
Angiopathy x
Vasodilation x
Bronchoconstriction x
Sinus bradycardia x
Atrioventricular block first degree x x x
Myocardial ischaemia x x
Unspecified disorder of skin and subcutaneous tissue x
Atrioventricular block second degree x x x
Blood pressure systolic decreased x
Blood pressure diastolic decreased x
Dropped beats x
Electrocardiogram PR prolongation x x x
Ear and labyrinth disorders x
Nodal block x
Wandering pacemaker x
Renal impairment x


Information about indications was extracted from the indications and usage sections of the labels.


Side effects:20


Side effects:56
Source:FDA Structured Product Label

regadenoson / regadenoson

Side effects:83

Color scheme:


    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    no frequency information
    not found on label